Immunic【IMUX】株式ニュース

名称	銘柄コード	市場	種別
Immunic Inc	IMUX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.0599	4.91%	1.2799	13:00:11

始値	安値	高値	終値	前日終値
1.23	1.22	1.30	1.24	1.22

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/28	19:30	PRNUS	Immunic to Participate in Industry and Scientific..
2024/5/25	05:06	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
2024/5/08	20:20	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/08	19:45	EDGAR2	Form 8-K - Current report
2024/5/08	19:30	PRNUS	Immunic, Inc. Reports First Quarter 2024 Financial Results..
2024/5/06	19:30	PRNUS	Immunic to Participate in Investor and Scientific..
2024/5/01	19:30	PRNUS	Immunic, Inc. to Announce Financial Results for the First..
2024/4/30	19:30	PRNUS	Immunic Announces Publication of Extended Data From Phase 2..
2024/4/04	19:30	PRNUS	Immunic to Host MS R&D Day and Participate in Investor..
2024/3/20	19:30	PRNUS	Immunic Receives Notice of Allowance for..
2024/3/09	06:05	EDGAR2	Form 8-K - Current report
2024/3/07	20:30	PRNUS	Immunic to Participate in Investor and Scientific..
2024/3/07	11:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	11:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	11:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	11:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	11:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	11:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/29	20:30	PRNUS	Immunic Presents Data From Phase 2 CALLIPER and CALVID-1..
2024/2/22	20:38	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/22	20:35	EDGAR2	Form 8-K - Current report
2024/2/22	20:30	PRNUS	Immunic, Inc. Reports Year End 2023 Financial Results and..
2024/2/15	20:30	PRNUS	Immunic, Inc. to Announce Financial Results for the Year..
2024/2/15	06:05	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	22:47	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	21:55	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	06:36	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2024/2/05	22:30	EDGAR2	Form DEF 14A - Other definitive proxy statements
2024/2/01	20:30	PRNUS	Immunic to Participate in Investor and Scientific..
2024/1/25	07:05	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2024/1/20	06:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	06:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	06:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	06:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/20	06:05	EDGAR2	Form D - Notice of Exempt Offering of Securities
2024/1/17	06:12	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/1/10	23:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/1/05	20:41	EDGAR2	Form 8-K - Current report
2024/1/05	20:35	PRNUS	Immunic Highlights 2023 Accomplishments and Upcoming..
2024/1/05	20:30	PRNUS	Immunic, Inc. Announces Private Placement of up to $240..
2023/12/21	22:30	EDGAR2	Form 8-K - Current report
2023/11/23	06:20	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2023/11/21	20:30	PRNUS	Immunic Receives Notice of Allowance for United States..
2023/11/14	20:38	EDGAR2	Form 8-K - Current report
2023/11/14	20:30	PRNUS	Immunic, Inc. Reports Third Quarter 2023 Financial Results..
2023/11/07	20:30	PRNUS	Immunic to Announce Financial Results for the Third Quarter..
2023/11/02	19:30	PRNUS	Immunic Receives Notice of Allowance for United States..
2023/10/26	19:30	PRNUS	Immunic to Participate in Scientific and Industry..
2023/10/19	05:05	EDGAR2	Form 8-K - Current report
2023/10/16	19:30	PRNUS	Immunic Presents Data From Phase 2 CALDOSE-1 Trial of..